Evidence map›Paper›PMID 33101234›Full record

ArticleFrontiers in microbiology2020

Lymphoid Tissue-Resident

Koji Hosomi, Naoko Shibata, Atsushi Shimoyama, Tomoya Uto, Takahiro Nagatake, Yoko Tojima, Tomomi Nishino, Haruko Takeyama, Koichi Fukase, Hiroshi Kiyono and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. The Safety ofViruses · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Chemically SynthesizedFrontiers in pharmacology · 2021
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Koji HosomiLaboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research, Ibaraki, Japan.
Naoko ShibataLaboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research, Ibaraki, Japan.
Atsushi ShimoyamaGraduate School of Science, Osaka University, Toyonaka, Japan.
Tomoya UtoGraduate School of Science, Osaka University, Toyonaka, Japan.
Takahiro NagatakeLaboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research, Ibaraki, Japan.
Yoko TojimaLaboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research, Ibaraki, Japan.
Tomomi NishinoLaboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research, Ibaraki, Japan.
Haruko TakeyamaResearch Organization for Nano and Life Innovation, Waseda University, Tokyo, Japan.
Koichi FukaseGraduate School of Science, Osaka University, Toyonaka, Japan.
Hiroshi KiyonoInternational Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Jun KunisawaLaboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research, Ibaraki, Japan.
National Institute of Biomedical Innovation, Health and Nutrition · JPOsaka University · JPWaseda University · JPChiba University · JPKobe University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymphoid-tissue-resident commensal bacteria (LRCs), including

Indexed as

apoptosisdendritic cellsinducible nitric oxide synmaselipopolysaccharidlymphoid-tissue-resident commensal bacteriamitochondrial respiration

Identifiers

PMID33101234
PMCPMC7545135
OpenAlexW3088413739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.